Skip to main content
. 2020 Sep 25;21(19):7077. doi: 10.3390/ijms21197077
ACN acetonitrile
AEA anandamide
2-AG 2-arachidonoylglycerol
ANOVA analysis of variance
BP blood pressure
BT bleeding time
BW body weight
CBD cannabidiol
CRC concentration response curve
CTR control
DEA docosatetraenoyl ethanolamide
DHEA docosahexaenoyl ethanolamide
EPEA eicosapentaenoyl ethanolamide
FAAH fatty acid amide hydrolase
HEA homo-γ-linolenyl ethanolamide
HR heart rate
LEA linolenoyl ethanolamide
2-LG linoleoylglycerol
LV left ventricle
MCT monocrotaline
NAGly N-arachidonoyl glycine
OEA oleoyl ethanolamide
PAH pulmonary arterial hypertension
PH pulmonary hypertension
PAI-1 plasminogen activator inhibitor type 1
PEA palmitoyl ethanolamide
POEA palmitoleoyl ethanolamide
rPAs rat pulmonary arteries
RVSP right ventricular systolic pressure
RV right ventricle
SBP systolic blood pressure
SEA stearoyl ethanolamide
TF tissue factor
t-PA tissue plasminogen activator
vWF von Willebrand factor